Novel symmetrical 1,4-Disubstituted-bis-1,2,3-Triazoles: synthesis by double CuAAC and cytotoxicity evaluation

Descrição

Tipo

Artigo de periódico

Título alternativo

Primeiro orientador

Membros da banca

Resumo

Background: A series of symmetrical 1,4-disubstituted bis-1,2,3-triazoles was prepared by double copper catalyzed Azide-alkyne Cycloaddition (CuAAC) from aliphatic bis-azides and a tetraethylene glycol bis-azide derivative. The eighteen novel compounds were evaluated in vitro for their cytotoxic activity against two human tumor cell lines: Human breast adenocarcinoma (MDA-MB 231) and ovarian adenocarcinoma (TOV-21G). Results and Conclusion: The results of colorimetric MTT assays showed that compounds 4j and 4q exhibited a better selectivity index and cell viability comparable with the standard drug doxorubicin. These compounds induced apoptosis in both tested cell lines, as assessed by BrdU assay. The results suggest that these structurally simple compounds may be promising prototypes for antitumoral agents.

Abstract

Assunto

Triazóis, Apoptose, Citotoxidade de mediação celular, Agentes antineoplásicos, Química farmacêutica

Palavras-chave

Symmetrical bis-1, 2, 3-triazoles, Bis-azides, Double CuAAC, Cytotoxicity, BrdU, Apoptosis, Cancer

Citação

Curso

Endereço externo

https://www.eurekaselect.com/article/93875

Avaliação

Revisão

Suplementado Por

Referenciado Por